(Q52404613)

1 May 2018

title

Empirical antibiotic therapy in neutropenic cancer patients. (English)

1 reference

1 May 2018

author name string

J Klastersky

series ordinal

1

1 reference

1 May 2018

publication date

1 January 1993

1 reference

1 May 2018

European Journal of Cancer

published in

1 reference

1 May 2018

volume

29A Suppl 1

1 reference

1 May 2018

page(s)

S6-10

1 reference

1 May 2018

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980253-9

7 January 2021

Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980253-9

7 January 2021

Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980253-9

7 January 2021

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980253-9

7 January 2021

Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980253-9

7 January 2021

Management of fever of unknown origin in patients with neoplasms and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980253-9

7 January 2021

Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980253-9

7 January 2021

Synergistic combinations of antibiotics in gram-negative bacillary infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980253-9

7 January 2021

Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980253-9

7 January 2021

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980253-9

7 January 2021

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980253-9

7 January 2021

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980253-9

7 January 2021

10.1016/S0959-8049(05)80253-9

Identifiers

DOI

1 reference

1 May 2018

1 reference

1 May 2018